| Product Code: ETC9967649 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United States (US) Hepatitis C Testing Market Overview |
3.1 United States (US) Country Macro Economic Indicators |
3.2 United States (US) Hepatitis C Testing Market Revenues & Volume, 2021 & 2031F |
3.3 United States (US) Hepatitis C Testing Market - Industry Life Cycle |
3.4 United States (US) Hepatitis C Testing Market - Porter's Five Forces |
3.5 United States (US) Hepatitis C Testing Market Revenues & Volume Share, By Test Kits, 2021 & 2031F |
3.6 United States (US) Hepatitis C Testing Market Revenues & Volume Share, By Technique, 2021 & 2031F |
3.7 United States (US) Hepatitis C Testing Market Revenues & Volume Share, By End-User, 2021 & 2031F |
4 United States (US) Hepatitis C Testing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness and screening initiatives for Hepatitis C in the US |
4.2.2 Technological advancements in Hepatitis C testing methods |
4.2.3 Rising prevalence of Hepatitis C infections in the US population |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for Hepatitis C testing products |
4.3.2 High cost associated with Hepatitis C testing procedures |
4.3.3 Limited access to testing facilities in certain regions of the US |
5 United States (US) Hepatitis C Testing Market Trends |
6 United States (US) Hepatitis C Testing Market, By Types |
6.1 United States (US) Hepatitis C Testing Market, By Test Kits |
6.1.1 Overview and Analysis |
6.1.2 United States (US) Hepatitis C Testing Market Revenues & Volume, By Test Kits, 2021- 2031F |
6.1.3 United States (US) Hepatitis C Testing Market Revenues & Volume, By Hepatitis C Antibody Test, 2021- 2031F |
6.1.4 United States (US) Hepatitis C Testing Market Revenues & Volume, By Hepatitis C RNA Quantitative Test, 2021- 2031F |
6.1.5 United States (US) Hepatitis C Testing Market Revenues & Volume, By Hepatitis C RNA Qualitative Test, 2021- 2031F |
6.1.6 United States (US) Hepatitis C Testing Market Revenues & Volume, By Hepatitis C RIBA, 2021- 2031F |
6.1.7 United States (US) Hepatitis C Testing Market Revenues & Volume, By Hepatitis C Genotype, 2021- 2031F |
6.1.8 United States (US) Hepatitis C Testing Market Revenues & Volume, By Viral Load, 2021- 2031F |
6.2 United States (US) Hepatitis C Testing Market, By Technique |
6.2.1 Overview and Analysis |
6.2.2 United States (US) Hepatitis C Testing Market Revenues & Volume, By Immunoassays, 2021- 2031F |
6.2.3 United States (US) Hepatitis C Testing Market Revenues & Volume, By Polymerase Chain Reaction (PCR), 2021- 2031F |
6.2.4 United States (US) Hepatitis C Testing Market Revenues & Volume, By Others, 2021- 2031F |
6.3 United States (US) Hepatitis C Testing Market, By End-User |
6.3.1 Overview and Analysis |
6.3.2 United States (US) Hepatitis C Testing Market Revenues & Volume, By Hospital and Clinics, 2021- 2031F |
6.3.3 United States (US) Hepatitis C Testing Market Revenues & Volume, By Diagnostic Laboratories, 2021- 2031F |
6.3.4 United States (US) Hepatitis C Testing Market Revenues & Volume, By Others, 2021- 2031F |
7 United States (US) Hepatitis C Testing Market Import-Export Trade Statistics |
7.1 United States (US) Hepatitis C Testing Market Export to Major Countries |
7.2 United States (US) Hepatitis C Testing Market Imports from Major Countries |
8 United States (US) Hepatitis C Testing Market Key Performance Indicators |
8.1 Number of individuals screened for Hepatitis C annually |
8.2 Adoption rate of new Hepatitis C testing technologies in the US |
8.3 Percentage of population tested for Hepatitis C in high-risk demographics |
9 United States (US) Hepatitis C Testing Market - Opportunity Assessment |
9.1 United States (US) Hepatitis C Testing Market Opportunity Assessment, By Test Kits, 2021 & 2031F |
9.2 United States (US) Hepatitis C Testing Market Opportunity Assessment, By Technique, 2021 & 2031F |
9.3 United States (US) Hepatitis C Testing Market Opportunity Assessment, By End-User, 2021 & 2031F |
10 United States (US) Hepatitis C Testing Market - Competitive Landscape |
10.1 United States (US) Hepatitis C Testing Market Revenue Share, By Companies, 2024 |
10.2 United States (US) Hepatitis C Testing Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here